| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| lampalizumab | complement factor d | NA | Clinical trial target | TTD , DGIDB | Geographic Atrophy[MeSHID:D057092] Retina[MeSHID:D012160] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
63.65 | phase 3 | antibody |
| click here to return to the previous page | ||||||||